Escara, Renita .
HRN: 17-34-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/24/2024
01/31/2024
IV
4.5g
Q8
Sick Euthyroid; Cannot Totally Rule Out Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes